Diabetes: Medtronic launches FDA bid for 1st automated insulin pump

June 8, 2012 by MassDevice staff

Medtronic filed for FDA pre-market approval for the world's first insulin pump with an automated system to suspend insulin delivery when glucose levels get too low.

insulin management

Medical device industry titan Medtronic (NYSE:MDT) filed a bid for FDA approval of its MiniMedR 530G system, which the company bills as the world's first insulin pump that delivers and halts insulin automatically, based on sensor readings of a patient's glucose levels.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp